160 related articles for article (PubMed ID: 30059751)
1. Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.
Li J; Li B; Jiang Q; Zhang Y; Liu A; Wang H; Zhang J; Qin Q; Hong Z; Li BA
Gene; 2018 Nov; 677():211-227. PubMed ID: 30059751
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis.
Mun MJ; Kim TH; Hwang JY; Jang WC
Maturitas; 2015 Jun; 81(2):256-65. PubMed ID: 25882760
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D Receptor Gene Polymorphism: Association with Susceptibility to Early-Onset Breast Cancer in Iranian, BRCA1/2-Mutation Carrier and non-carrier Patients.
Shahabi A; Alipour M; Safiri H; Tavakol P; Alizadeh M; Milad Hashemi S; Shahabi M; Halimi M
Pathol Oncol Res; 2018 Jul; 24(3):601-607. PubMed ID: 28780723
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor BsmІ polymorphism and ovarian cancer risk: a meta-analysis.
Qin X; Lu Y; Qin A; Chen Z; Peng Q; Deng Y; Xie L; Wang J; Li R; Zeng J; Li S; Zhao J
Int J Gynecol Cancer; 2013 Sep; 23(7):1178-83. PubMed ID: 23873178
[TBL] [Abstract][Full Text] [Related]
5. Contribution of VDR polymorphisms to type 1 diabetes susceptibility: Systematic review of case-control studies and meta-analysis.
Tizaoui K; Kaabachi W; Hamzaoui A; Hamzaoui K
J Steroid Biochem Mol Biol; 2014 Sep; 143():240-9. PubMed ID: 24742873
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population.
Mostowska A; Sajdak S; Pawlik P; Lianeri M; Jagodzinski PP
Genet Test Mol Biomarkers; 2013 Mar; 17(3):183-7. PubMed ID: 23320576
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis.
Song GG; Lee YH
Immunol Invest; 2013; 42(7):661-72. PubMed ID: 24004063
[TBL] [Abstract][Full Text] [Related]
8. Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study.
Rashid MU; Muzaffar M; Khan FA; Kabisch M; Muhammad N; Faiz S; Loya A; Hamann U
PLoS One; 2015; 10(10):e0141562. PubMed ID: 26517870
[TBL] [Abstract][Full Text] [Related]
9. Association between VDR polymorphisms and rheumatoid arthritis disease: Systematic review and updated meta-analysis of case-control studies.
Tizaoui K; Hamzaoui K
Immunobiology; 2015 Jun; 220(6):807-16. PubMed ID: 25577294
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Receptor Gene BSMI, FOKI, APAI, and TAQI Polymorphisms and the Risk of Atopic Dermatitis.
Kılıç S; Sılan F; Hız MM; Işık S; Ögretmen Z; Özdemir Ö
J Investig Allergol Clin Immunol; 2016; 26(2):106-10. PubMed ID: 27164626
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor rs2228570 polymorphism and susceptibility to ovarian cancer: An updated meta-analysis.
Chen H; Zhu J
J Obstet Gynaecol Res; 2018 Mar; 44(3):556-565. PubMed ID: 29239065
[TBL] [Abstract][Full Text] [Related]
13. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
Shaker OG; Senousy MA
Clin Breast Cancer; 2019 Feb; 19(1):e220-e238. PubMed ID: 30309792
[TBL] [Abstract][Full Text] [Related]
14. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
Coşkun S; Şimşek Ş; Camkurt MA; Çim A; Çelik SB
Gene; 2016 Aug; 588(2):109-14. PubMed ID: 27155524
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
McKay JD; McCullough ML; Ziegler RG; Kraft P; Saltzman BS; Riboli E; Barricarte A; Berg CD; Bergland G; Bingham S; Brustad M; Bueno-de-Mesquita HB; Burdette L; Buring J; Calle EE; Chanock SJ; Clavel-Chapelon F; Cox DG; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover RN; Hunter DJ; Husing A; Kaaks R; Kolonel LN; Le Marchand L; Linseisen J; McCarty CA; Overvad K; Panico S; Purdue MP; Stram DO; Stevens VL; Trichopoulos D; Willett WC; Yuenger J; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):297-305. PubMed ID: 19124512
[TBL] [Abstract][Full Text] [Related]
16. The role of the rs1544410 polymorphism of vitamin D receptor gene in breast cancer susceptibility.
Li X; Huo X; Li W; Yang Q; Wang Y; Kang X
Cell Biochem Biophys; 2014 Dec; 70(3):1951-6. PubMed ID: 25064221
[TBL] [Abstract][Full Text] [Related]
17. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.
Raimondi S; Johansson H; Maisonneuve P; Gandini S
Carcinogenesis; 2009 Jul; 30(7):1170-80. PubMed ID: 19403841
[TBL] [Abstract][Full Text] [Related]
18. Associations between vitamin D receptor polymorphisms and susceptibility to Behcet's disease: A meta-analysis.
Mirfeizi Z; Tabaei S; Ravanshad Y; Hashemzadeh K; Kharazmi E; Mehrad-Majd H
Immunol Invest; 2018 May; 47(4):389-402. PubMed ID: 29388852
[TBL] [Abstract][Full Text] [Related]
19. No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population.
Pan XM; Li DR; Yang L; Wang EY; Chen TY; Liu YJ; Liu M; Liao ZG
DNA Cell Biol; 2009 Oct; 28(10):521-5. PubMed ID: 19563249
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis.
Mocellin S; Nitti D
Cancer; 2008 Nov; 113(9):2398-407. PubMed ID: 18816636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
